Omega-3 Supplements Affect Alzheimer's Symptoms
Main Category: Alzheimer's / DementiaAlso Included In: Nutrition / Diet; Depression
Article Date: 24 Jun 2007 - 16:00 PDT
| Patient / Public: | ![]() |
4.2 (5 votes) |
| Healthcare Prof: | ![]() |
3.67 (3 votes) |
Omega-3 supplements can, in certain cases, help combat the depression and agitation symptoms associated with Alzheimer's disease, according to a clinical study conducted at the Swedish medical university Karolinska Institutet.
A number of epidemiological studies have shown that eating fatty fish provides a certain degree of protection against Alzheimer's and other dementia diseases - an effect often thought attributable to the omega-3 fatty acids it contains. Some studies also suggest that omega-3 can have a therapeutic effect on some psychiatric conditions.
Researchers at Karolinska Institutet and Uppsala University have now examined whether omega-3 supplementation has any effect on the psychiatric symptoms associated with Alzheimer's disease. Just under 200 patients with mild Alzheimer's were divided into two groups, one of which received omega-3, and one a placebo. The study lasted for one year.
There was no observable difference in therapeutic effect between the patients receiving the omega-3 and the placebo group. However, when the researchers took into account which of the patients carried the susceptibility gene APOE ?4 and which did not, an appreciable difference appeared. Carriers of the gene who had received active treatment responded positively to the omega-3 as regards agitation symptoms, while non-bearers of the gene showed an improvement in depressive symptoms.
The team points out that no general therapeutic recommendations can be made from the results until larger studies on individuals with more pronounced neuropsychiatric symptoms are conducted.
###
Publication:
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms Yvonne Freund-Levi, Hans Basun, Tommy Cederholm, Gerd Faxén-Irving, Anita Garlind, Mikaela Grut, Inger Vedin, Jan Palmblad, Lars-Olof Wahlund and Maria Eriksdotter-Jönhagen
International Journal of Geriatric Psychiatry, doi 10.1002/gps.1857
Published online 21 June 2007; http://www3.interscience.wiley.com/cgi-bin/jissue/112161699
For further information, please contact:
Senior Physician, PhD Student Yvonne Freund-Levi
Department of Neurobiology, Care Sciences and Society
Professor Lars-Olof Wahlund
Department of Neurobiology, Care Sciences and Society
Associate Professor Maria Eriksdotter-Jönhagen
Department of Neurobiology, Care Sciences and Society
Contact: Sabina Bossi
Karolinska Institutet
Visit our alzheimer's / dementia section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/74906.php>
APA
http://www.medicalnewstoday.com/releases/74906.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






